US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% NVDA $233.95 ▲+0.00% JNJ $256.03 ▲+0.00% SNDK $1,719.99 ▲+0.00%
FinancialContent

Generation Bio Co. - Common stock (NQ:GBIO)

5.340 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Generation Bio Co. - Common stock

< Previous 1 2 3 4 5 Next >
News headline image
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
Which stocks are moving after the closing bell on Friday? ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q2 2024 ↗
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Generation Bio Reports Second Quarter 2024 Financial Results
Cash balance of $217 million still expected to fund operations into 2H 2027 
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
From Generation Bio Co.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024 ↗
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023 ↗
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
From Generation Bio Co.
Via GlobeNewswire
News headline image
Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket ↗
Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results. 
Via Benzinga
News headline image
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. 
Via Benzinga
News headline image
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
From Generation Bio Co.
Via GlobeNewswire
News headline image
Top 4 Health Care Stocks That May Rocket Higher This Month ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
< Previous 1 2 3 4 5 Next >